Skip to content

Red Flags and Safety Concerns

TL;DR — This page collects what the literature documents as dangerous in thoracic aortic disease, with the evidence grade attached. Acute dissection presents with severe or worst-ever pain in 93–94% of registry patients, but the classic signs are minority findings (aortic regurgitation murmur 31.6%, pulse deficit 15.1%, normal ECG in 31.3%), and 6.4% of dissections are painless — a subgroup presenting instead with syncope, heart failure or stroke and dying more often (Pape 2015, PMID 26205591; Hagan 2000, PMID 10685714; Park 2004, PMID 15473405). Roughly 1 in 3 dissections is initially misdiagnosed, most often as acute coronary syndrome, stroke or pulmonary embolism, with a median 4.3 h from emergency-department arrival to diagnosis (Lovatt 2022, PMID 34968970; Harris 2011, PMID 21969019). Screening is documented as high-yield in first-degree relatives (33% newly affected across 53 studies; Mariscalco 2018, PMID 30371227). The best-evidenced modifiable exposure is blood pressure (hypertension HR ~2.7–3.6; pooled RR 3.07; population-attributable risk ~54%) (Hibino 2022, PMID 34743557; Landenhed 2015, PMID 25609416); pregnancy carries a 4-fold cohort-crossover increase in dissection/rupture risk (Kamel 2016, PMID 27492904); the exertion and drug cautions rest on case series and contested pharmacoepidemiology, not trials.

1. Recognizing an acute aortic emergency

Documented symptom and sign frequencies

Feature Frequency Source
Severe or worst-ever pain 93% (type A), 94% (type B) — unchanged across 17 years of registry enrolment (Pape 2015, PMID 26205591)
Chest pain 83% (type A), 71% (type B) (Pape 2015, PMID 26205591)
Chest / back / syncope in misdiagnosed-cohort pooled data 67.5% / 24.8% / 6.8% (Lovatt 2022, PMID 34968970)
Aortic regurgitation murmur 31.6% (Hagan 2000, PMID 10685714)
Pulse deficit 15.1% (Hagan 2000, PMID 10685714)
Syncope 13% (96/728); mortality 34% vs 23% without syncope (Nallamothu 2002, PMID 12427495)
Painless dissection (all types) 6.4% (63/977) (Park 2004, PMID 15473405)
Painless type B specifically 3.7% (43/1,162) (Tolenaar 2013, PMID 26798680)
Normal initial chest radiograph / ECG 12.4% / 31.3% (Hagan 2000, PMID 10685714)

The 2000 IRAD report's own conclusion was that "classic findings are often absent" and that a high index of suspicion is required (Hagan 2000, PMID 10685714); the 20-year synthesis found presenting symptoms and physical findings essentially unchanged over two decades, while imaging and treatment changed substantially (Evangelista 2018, PMID 29685932).

Pain quality is a weaker discriminator than pain onset and severity. Registry data track "severe or worst-ever" pain and abruptness rather than the textbook tearing/ripping descriptor; delays in diagnosis clustered in patients whose pain was not abrupt or not localised to chest/back (Harris 2011, PMID 21969019). Radiating pain was one of three independent predictors of type A dissection occurring at diameters <5.5 cm (OR 2.08) — i.e. symptom character carries information that diameter does not (Pape 2007, PMID 17709637).

Presentations without pain. Painless dissection is older (66.6 vs 61.9 years), more often type A (74.6%), and presents with syncope (33.9% vs 11.7%), congestive heart failure (19.7% vs 3.9%) or stroke (11.3% vs 4.7%); in-hospital mortality was 33.3% vs 23.2% (Park 2004, PMID 15473405). Painless type B patients waited longer for diagnosis (median 34 vs 19 h) with a mortality trend of 18.6% vs 9.9% (Tolenaar 2013, PMID 26798680). Age erodes the classic picture further: in patients ≥70, typical abrupt chest/back pain and typical signs were less common, hypotension more common (46% vs 32%), and in-hospital mortality 43% vs 28% (Mehta 2002, PMID 12204498).

Neurological presentations. Syncope is associated with cardiac tamponade (OR 3.1) and stroke (OR 3.5) rather than being an independent mortality risk once those are accounted for (Nallamothu 2002, PMID 12427495). Preoperative central neurological deficits were present in 24.5% of a surgical type A series and were associated with dissected carotid arteries (OR 9.2) and late arrival to surgery >6 h from symptom onset (OR 2.7) — the authors attribute part of this to neurological symptoms driving an initial stroke misdiagnosis (Niclauss 2013, PMID 24184458). Viewed from the stroke side, acute type A dissection accounted for 0.31% of suspected acute strokes and 1.70% of ischaemic strokes presenting within 4 h; none of those patients reported chest pain, and low right-arm systolic pressure (≤110 mm Hg) plus elevated D-dimer flagged them (Sakamoto 2016, PMID 27070149).

The misdiagnosis problem, quantified

  • Pooled across 12 studies (n=1,663), 33.8% of acute aortic dissections were initially misdiagnosed. The named competing labels are acute coronary syndrome, stroke and pulmonary embolism; error was driven by symptoms overlapping those diseases, by absence of typical features such as a widened mediastinum, and by concurrent conditions such as heart failure (Lovatt 2022, PMID 34968970).
  • Median time from ED arrival to diagnosis was 4.3 h (Q1–Q3 1.5–24 h) and from diagnosis to surgery a further 4.3 h. Delay was concentrated in women, in atypical or painless presentations, in patients without pulse deficit or hypotension, and in those first presenting to a non-tertiary hospital (delay-time ratio 3.34); fever produced the largest single delay ratio (5.11) (Harris 2011, PMID 21969019).
  • Even among emergency transfers to an aortic centre with a presumed aortic diagnosis, 11.4% were wrong — all attributable to imaging misinterpretation, commonly motion artefact (16%) or post-surgical change (25%) (Holmes 2021, PMID 34838743).

What the stakes of delay look like in the data

Population-based ascertainment shows the measurement problem behind all hospital statistics: 48.6% of incident type A dissections in the Oxford Vascular Study died before hospital assessment, and 30-day fatality among those who did reach hospital was 47.4% (Howard 2013, PMID 23599348). Within hospitals, unoperated type A mortality was 58% versus 26% with surgery in early IRAD (Hagan 2000, PMID 10685714). Detailed mortality trends: aortic-dissection.

Structured detection tools and the awareness response

  • The aortic dissection detection risk score (ADD-RS) built from the 12 guideline high-risk markers captured 95.7% of 2,538 registry dissections with ≥1 marker; 4.3% scored zero, and of those with a chest radiograph, 48.6% still had a widened mediastinum (Rogers 2011, PMID 21555704).
  • Prospectively (ADvISED, 1,850 patients, 13% acute aortic syndrome prevalence), ADD-RS ≤1 combined with D-dimer <500 ng/mL gave a failure rate of 0.3% while ruling out 49.9% of patients; D-dimer alone had sensitivity 96.7% but specificity 64% and missed 8 syndromes (Nazerian 2018, PMID 29030346). Biomarker detail: biomarkers.
  • THINK AORTA is the diagnostic-awareness campaign response, named in the surgical literature as an improvement lever for exactly the transfer-misdiagnosis problem measured above (Holmes 2021, PMID 34838743). Campaign structure, reach and patient-organisation origins: patient-experience-and-advocacy. No controlled before/after evaluation of campaign effect on misdiagnosis rates surfaced in this session.

2. Who the literature says warrants screening

Trigger Documented yield or rationale
First-degree relatives of patients with root/ascending aneurysm or dissection Across 53 studies and 2,696 screened relatives, newly affected individuals were found in 33% of first-degree, 24% of second-degree and 15% of third-degree relatives; familial disease was mostly single-gene, autosomal dominant with incomplete penetrance (Mariscalco 2018, PMID 30371227). Guideline-endorsed as screening aortic imaging (Isselbacher 2022, PMID 36322642)
Relatives of bicuspid aortic valve patients TTE screening to detect BAV and root/ascending dilation (Isselbacher 2022, PMID 36322642); see bicuspid-aortopathy
Syndromic features Under the revised Ghent nosology, aortic root aneurysm and ectopia lentis are the cardinal features — together they establish Marfan syndrome without family history; otherwise a pathogenic FBN1 variant or a systemic-feature score is required (Loeys 2010, PMID 20591885). Marfanoid habitus, lens dislocation and family sudden death are therefore entry points to aortic imaging, not incidental findings
Known pathogenic-variant carriers Cascade genetic testing of biological relatives with imaging of carriers (Isselbacher 2022, PMID 36322642); gene-by-gene detail in genetics-of-taa

Two limits are documented rather than assumed: no study has evaluated the predictive accuracy, clinical effectiveness or cost-effectiveness of any formal screening programme in non-syndromic thoracic aortic disease (Mariscalco 2018, PMID 30371227), and the burden of cascade screening falls largely on probands and families (patient-experience-and-advocacy). Screening logistics and imaging yield: imaging-and-surveillance.

3. Documented cautions, with their evidence quality

Blood pressure — the strongest evidence in this section

  • Prospective cohort (30,412 people, up to 20 years): hypertension present in 86% of those who later dissected, HR 2.64, population-attributable risk 54% (Landenhed 2015, PMID 25609416).
  • Two prospective cohorts plus meta-analysis (7 studies, 2,818 dissections, 4.56 million participants): hypertension HR 3.57 (J-SHC) and 2.68 (UK Biobank), summary RR 3.07; risk rose dose-dependently and became significant above SBP 132 and DBP 75 mm Hg — i.e. within the conventionally "normal" range (Hibino 2022, PMID 34743557).
  • Population data show the control gap: 46% of Oxford Vascular Study dissection patients had at least one recorded systolic pressure ≥180 mm Hg in the preceding 5 years despite 67.3% being on antihypertensives, and premorbid pressure was higher in those whose dissection was immediately fatal (151.2 vs 137.9 mm Hg) (Howard 2013, PMID 23599348). Drug choice and targets: medical-therapy.

Pregnancy in aortopathy

  • Population signal: in a cohort-crossover of 6.57 million pregnancies, aortic dissection or rupture occurred at 5.5 per million during pregnancy and the 3 months postpartum versus 1.4 per million in the equivalent window one year later — IRR 4.0 (95% CI 2.0–8.2) (Kamel 2016, PMID 27492904).
  • Marfan cohorts: across 133 pregnancies in 89 women followed in Marfan units, the aortic event rate was 3.7% (2 type A dissections, 1 type B, 2 with ≥3 mm growth), concentrated in the third trimester and puerperium; pre-gestational diameter ≥40 mm showed a non-significant association (p=0.058) (Martín 2021, PMID 34481752). A Taiwanese nationwide analysis (794 Marfan pregnancies vs 3.3 million) reported severe aortic complications in 1.1% vs 0.0005% and 42-day maternal mortality 0.1% vs 0.02%, with elevated aortic-event risk persisting over 10.7 years of follow-up (Chang 2025, PMID 41475970).
  • Where the diameter rule fails: a literature review of 72 published pregnancy-associated dissections found 8 events in Marfan women with root diameter ≤40 mm and 6 in women on beta-blockers, and events not confined to the third trimester — the authors argue current diameter-based stratification misses cases (Smith 2017, PMID 28371362).
  • Gene-specific: reviews of pregnancy in aortopathy identify Marfan, bicuspid aortic valve, Loeys-Dietz, vascular Ehlers-Danlos, Turner syndrome and non-syndromic familial TAAD as carrying elevated dissection risk in the third trimester and early postpartum, with residual high risk in Marfan/Loeys-Dietz/vEDS even after prior repair (Stewart 2013, PMID 27708702). Vascular EDS remains the extreme: fatal aortic rupture at term in a woman whose diagnosis was made only post mortem, with celiprolol then offered to relatives (Tadakawa 2026, PMID 42092737).
  • Guideline thresholds for surgery before pregnancy (2022 ACC/AHA §8.3, verified against the guideline text; Isselbacher 2022, PMID 36322642). The condition, not the diameter alone, sets the trigger:
Condition Surgery before pregnancy recommended May be considered
Marfan syndrome Root >4.5 cm (COR 1, C-LD) Root 4.0–4.5 cm (COR 2b, C-LD), especially with growth ≥0.3 cm/y or family history of dissection
Loeys-Dietz (TGFB2/TGFB3) ≥4.5 cm — reasonable (COR 2a, C-EO) —
Loeys-Dietz (TGFBR1/TGFBR2/SMAD3) — ≥4.0 cm (COR 2b, C-EO)
Non-syndromic heritable TAD ≥4.5 cm (COR 1, C-EO) 4.0–4.4 cm (COR 2b, C-EO), depending on molecular diagnosis, family history, growth rate
Turner syndrome ASI ≥2.5 cm/m² (COR 1, C-LD) —
Bicuspid aortic valve (no Turner/HTAD) ≥5.0 cm (COR 1, C-EO) —
Sporadic root / ascending aneurysm ≥5.0 cm (COR 1, C-EO) —

Note the evidence grade: every one of these thresholds is C-LD or C-EO — limited data or expert opinion, not trial evidence. Before pregnancy the guideline also recommends aortic imaging to establish diameters, genetic counselling, and counselling on dissection risk (all COR 1, C-LD). Full COR/LOE context: guidelines. Patient-priority framing: pregnancy-associated dissection is ranked a top research priority by patient stakeholders despite its rarity (patient-experience-and-advocacy).

Heavy resistance exercise and Valsalva

The evidence is a case series plus physiology, and should be read as such. Thirty-one acute dissections occurring during severe exertion — predominantly weightlifting — were assembled from a university database and referred reports: 30/31 male, mean age 47.3, 27/31 ascending, mean aortic diameter only 4.63 cm, 32.2% died. The authors' inference is that moderate aortic dilation confers vulnerability to exertion-triggered dissection well below surgical thresholds (Hatzaras 2007, PMID 16847387). The guideline's position is expert-opinion grade: patients with significant aortic disease should be counselled to avoid intense isometric exercise (heavy weightlifting, Valsalva-requiring activity), burst exertion and collision sports (COR 1, LOE C-EO), while 30–60 minutes of mild-to-moderate aerobic activity 3–4 days a week is reasonable where blood pressure is controlled (COR 2a, C-LD). The guideline states the boundary explicitly — expert committees agree that heavy lifting with Valsalva (which can drive systolic pressure above 300 mm Hg) should be avoided and that light weightlifting and low-intensity aerobic exercise are safe, but "no uniform consensus exists about the safety of intermediate-level static and aerobic exercise," so intensity is to be individualised (Isselbacher 2022, PMID 36322642). The full activity-restriction picture, including the counter-evidence that restricted young patients exercise anyway without detected aortic harm, is on medical-therapy and patient-experience-and-advocacy.

Cocaine and stimulants

Forty-five cocaine-related dissections (11 institutional, 34 published case reports) were young (41.3 ± 8.67 years) and male (88.9%), 75% type A, with a median of 1 hour from last cocaine use to symptom onset; in-hospital mortality was 21.4% and a further 11.9% died before reaching hospital (Greve 2020, PMID 33118742). A 2026 review argues cocaine and amphetamine use is strongly associated with type B dissection in younger patients presenting with more complicated disease, and notes that stimulant-positive patients are routinely excluded from the trials that define management — so the evidence base for them is retrospective by construction (Matabele 2026, PMID 42285641).

Fluoroquinolones — a contested association, not a settled harm

Cohort data give a 60-day HR of 1.66 for aneurysm/dissection versus amoxicillin, with an absolute excess of 82 cases per million treatment episodes and the signal driven by aneurysm (HR 1.90) rather than dissection (HR 0.93) (Pasternak 2018, PMID 29519881). Disease-matched active-comparator work then found the association versus azithromycin in pneumonia (HR 2.57) but null versus trimethoprim-sulfamethoxazole in urinary infection (HR 0.99), and the amoxicillin comparison attenuated from 1.54 to 1.13 (95% CI 0.96–1.33) once baseline aortic imaging was required — consistent with surveillance bias; absolute rates were <0.1% (Gopalakrishnan 2020, PMID 32897307). The full study-by-study ledger and the calcium-channel-blocker signal live on medical-therapy and are not re-litigated here.

Deceleration trauma

Blunt traumatic aortic injury is a named topic of the 2022 guideline (Isselbacher 2022, PMID 36322642). In a multicentre series of 17 ascending/arch traumatic injuries, the mechanisms were motor-vehicle crash (47%) and motorcycle crash (41%), with observed in-hospital mortality 53% and death attributable to the aortic injury in 45% of those cases (Mosquera 2013, PMID 23294894). Contemporary endovascular repair series report 30-day mortality of 8% with durable exclusion at 5 years, indicating that survival hinges on the injury being identified at all (Patel 2020, PMID 31991136); missed injury presenting months later as a pseudoaneurysm is a documented failure mode (Fang 2022, PMID 35801016).

4. During surveillance: findings that change urgency

  • New pain in a known aneurysm is itself the trigger for surgery. The 2022 guideline organises its recommendations across three presentation subsets — asymptomatic, stable symptomatic, and acute aortic syndrome — so symptom onset moves a patient between management categories, and its first surgical recommendation for the root and ascending aorta is unconditioned by size: in patients with aneurysms of the aortic root and ascending aorta who have symptoms attributable to the aneurysm, surgery is indicated (COR 1, LOE C-LD). The diameter thresholds that follow (≥5.5 cm, COR 1; ≥5.0 cm in experienced hands, COR 2a; growth ≥0.3 cm/y over 2 consecutive years or ≥0.5 cm in 1 year, COR 1) all apply to asymptomatic patients (Isselbacher 2022, PMID 36322642). Empirically, symptomatic and ruptured thoracic aneurysms cluster together: in a 75-patient surgical series, patients with pain or rupture were over-represented in the high-inflammatory-marker group, and the marker did not correlate with diameter at all (Lareyre 2018, PMID 29334754). Radiating pain independently predicted dissection at diameters below the elective threshold (OR 2.08) (Pape 2007, PMID 17709637).
  • Apparent rapid growth. Growth is a legitimate trigger but a noisy measurement: single-reading 95% confidence intervals on gated CT reach ±2.4–5.2 mm, the same magnitude as several years of true growth, which is why growth criteria require confirmation with the same technique across two intervals (imaging-and-surveillance).
  • Compression syndromes. Hoarseness from left recurrent laryngeal nerve compression (Ortner's/cardiovocal syndrome) with dysphagia and cough is a documented, if uncommon, presentation of arch and descending aneurysms — in the reported case an eccentric saccular aneurysm compressing trachea, oesophagus, left atrium and nerve simultaneously (Agarwal 2020, PMID 33005510). The evidence here is case-level, not epidemiological.
  • Diameter is not a sufficient reassurance criterion. 59% of type A dissections occurred below 5.5 cm and 40% below 5.0 cm (mean 5.3 cm) (Pape 2007, PMID 17709637) — the size paradox, resolved at population level in epidemiology-and-natural-history and risk-stratification-and-size-thresholds.

5. After repair

  • Surveillance findings peak early. In 267 dissection survivors, adverse imaging findings peaked at 6–12 months (5.6%) and rarely prompted immediate intervention (3.4%), yet imaging during that specific window was associated with lower adjusted mortality (HR 0.50, 95% CI 0.27–0.91); imaging in other intervals was not (Chaddha 2019, PMID 31614376).
  • False-lumen behaviour stratifies late risk. Post-discharge 3-year mortality in type B dissection was 13.7% with a patent false lumen, 22.6% with complete thrombosis, and 31.6% with partial thrombosis — an independent predictor of death (RR 2.69) (Tsai 2007, PMID 17652650). Full post-dissection degeneration data: aortic-dissection.
  • Endoleak and reintervention after endovascular repair. In arch-involving repair with parallel grafts, 28 endoleaks were detected on immediate post-operative CT in 27 of 33 patients, overall reintervention was 33%, and freedom from reintervention was 68% at 60 months; the authors conclude frequent radiological surveillance is mandatory because gutter-related leaks can drive sac enlargement (Dueppers 2021, PMID 34606961). Post-TEVAR imaging schedules: imaging-and-surveillance; device and technique detail: surgical-and-endovascular-repair.
  • Graft infection. The MAGIC case definition classifies clinical/surgical, radiological and laboratory criteria as major or minor — major clinical criteria include pus around a graft or direct communication with a non-sterile site; major radiological criteria include increasing perigraft gas on serial CT, or perigraft gas ≥7 weeks and fluid ≥3 months after implantation; major laboratory criteria are organisms from perigraft aspirates or explants (Lyons 2016, PMID 27771318). Prospective validation in 257 patients (137 adjudicated as infected) gave sensitivity 99% and specificity 61% against the cohort's own adjudication; treating MAGIC-"suspected" cases as not diseased raised both to 93%, and in that analysis thoracic grafts had the poorest sensitivity of any location (86%, 95% CI 73–95) (Anagnostopoulos 2021, PMID 34140225).
  • Mechanical valve conduits carry an anticoagulation trade-off. Total root replacement with a mechanical valved conduit is a near-certain correction of valve regurgitation but carries thromboembolic and bleeding risks, whereas valve-sparing root replacement avoids anticoagulation at the cost of ~1.3% per annum reoperation for aortic regurgitation — a rate a prospective multi-institutional study suggested underestimates true valve-related adverse events. Because these patients are on average in their 30s, cumulative lifetime valve-related complication risk is substantial (Treasure 2014, PMID 24986892). Operative choices: surgical-and-endovascular-repair.

Open questions

  • Can misdiagnosis be measurably reduced? Misdiagnosis has stayed near 1 in 3 (Lovatt 2022, PMID 34968970) while presenting features have not changed in 20 years of registry data (Evangelista 2018, PMID 29685932). ADD-RS plus D-dimer achieves a 0.3% failure rate prospectively (Nazerian 2018, PMID 29030346) and awareness campaigns are endorsed in the surgical literature (Holmes 2021, PMID 34838743), but no controlled evaluation of either strategy's effect on real-world misdiagnosis or time-to-diagnosis surfaced this session.
  • Can a pre-rupture or pre-dissection warning be detected at all? Half of type A deaths occur before hospital assessment (Howard 2013, PMID 23599348), most type A dissections occur below elective thresholds (Pape 2007, PMID 17709637), and the earliest documented signals are symptom-based (radiating pain, painless syncope/stroke presentations) rather than imaging-based (Park 2004, PMID 15473405).
  • Is the diameter-based pregnancy rule adequate? Events occur at root ≤40 mm and on beta-blockade, and outside the third trimester (Smith 2017, PMID 28371362), while cohort-level risk is unambiguous (IRR 4.0; Kamel 2016, PMID 27492904) — no prospective study has tested an alternative stratification.
  • What exertion is actually dangerous? The entire weightlifting caution rests on 31 collected cases at a mean 4.63 cm with no denominator (Hatzaras 2007, PMID 16847387) and expert-opinion guideline text (Isselbacher 2022, PMID 36322642).
  • Is the fluoroquinolone association causal? Unexposed-comparator and disease-matched active-comparator designs disagree, and requiring baseline imaging attenuates the signal to null (Pasternak 2018, PMID 29519881; Gopalakrishnan 2020, PMID 32897307).
  • How should stimulant-using patients be managed? They are systematically excluded from the trials defining dissection therapy, leaving no prospective evidence for a group presenting younger and more complicated (Matabele 2026, PMID 42285641; Greve 2020, PMID 33118742).

References

  1. Isselbacher EM, Preventza O, Hamilton Black J, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease. Circulation. 2022;146:e334-e482. PMID 36322642
  2. Isselbacher EM, Preventza O, Hamilton Black J, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease. J Am Coll Cardiol. 2022;80:e223-e393. PMID 36334952 — simultaneous co-publication of reference 1; guideline text on this page is cited to the Circulation version (PMID 36322642), verified against the full text in PMC (PMC9876736)
  3. Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283:897-903. PMID 10685714
  4. Pape LA, Awais M, Woznicki EM, et al. Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from IRAD. J Am Coll Cardiol. 2015;66:350-8. PMID 26205591
  5. Evangelista A, Isselbacher EM, Bossone E, et al. Insights from IRAD: a 20-year experience of collaborative clinical research. Circulation. 2018;137:1846-1860. PMID 29685932
  6. Park SW, Hutchison S, Mehta RH, et al. Association of painless acute aortic dissection with increased mortality. Mayo Clin Proc. 2004;79:1252-7. PMID 15473405
  7. Tolenaar JL, Hutchison SJ, Montgomery D, et al. Painless type B aortic dissection: insights from IRAD. Aorta (Stamford). 2013;1:96-101. PMID 26798680
  8. Nallamothu BK, Mehta RH, Saint S, et al. Syncope in acute aortic dissection: diagnostic, prognostic, and clinical implications. Am J Med. 2002;113:468-71. PMID 12427495
  9. Mehta RH, O'Gara PT, Bossone E, et al. Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol. 2002;40:685-92. PMID 12204498
  10. Niclauss L, Delay D, Ferrari E, Prêtre R. Impact of preoperative central neurologic dysfunction on patients undergoing emergency surgery for type A dissection. Ann Vasc Surg. 2014;28:1227-35. PMID 24184458
  11. Sakamoto Y, Koga M, Ohara T, et al. Frequency and detection of Stanford type A aortic dissection in hyperacute stroke management. Cerebrovasc Dis. 2016;42:110-6. PMID 27070149
  12. Lovatt S, Wong CW, Schwarz K, et al. Misdiagnosis of aortic dissection: a systematic review of the literature. Am J Emerg Med. 2022;53:16-22. PMID 34968970
  13. Harris KM, Strauss CE, Eagle KA, et al. Correlates of delayed recognition and treatment of acute type A aortic dissection (IRAD). Circulation. 2011;124:1911-8. PMID 21969019
  14. Holmes HR, Neal D, Freeman K, et al. Misdiagnosis of thoracic aortic disease occurs commonly in emergency transfers. Ann Thorac Surg. 2022;114:2202-2208. PMID 34838743
  15. Howard DPJ, Banerjee A, Fairhead JF, et al. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: Oxford Vascular Study. Circulation. 2013;127:2031-7. PMID 23599348
  16. Rogers AM, Hermann LK, Booher AM, et al. Sensitivity of the aortic dissection detection risk score: results from IRAD. Circulation. 2011;123:2213-8. PMID 21555704
  17. Nazerian P, Mueller C, Soeiro AM, et al. Diagnostic accuracy of the aortic dissection detection risk score plus D-dimer for acute aortic syndromes: the ADvISED prospective multicenter study. Circulation. 2018;137:250-258. PMID 29030346
  18. Mariscalco G, Debiec R, Elefteriades JA, et al. Systematic review of studies that have evaluated screening tests in relatives of patients affected by nonsyndromic thoracic aortic disease. J Am Heart Assoc. 2018;7:e009302. PMID 30371227
  19. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476-85. PMID 20591885
  20. Landenhed M, Engström G, Gottsäter A, et al. Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: a prospective cohort study. J Am Heart Assoc. 2015;4:e001513. PMID 25609416
  21. Hibino M, Otaki Y, Kobeissi E, et al. Blood pressure, hypertension, and the risk of aortic dissection incidence and mortality: J-SHC, UK Biobank, and a meta-analysis. Circulation. 2022;145:633-644. PMID 34743557
  22. Kamel H, Roman MJ, Pitcher A, Devereux RB. Pregnancy and the risk of aortic dissection or rupture: a cohort-crossover analysis. Circulation. 2016;134:527-33. PMID 27492904
  23. Martín CE, Evangelista A, Teixidó G, et al. Aortic events in pregnant patients with Marfan syndrome: lessons from a multicenter study. Rev Esp Cardiol (Engl Ed). 2022;75:552-558. PMID 34481752
  24. Chang FC, Chen CY, Hsieh MJ, et al. Maternal and neonatal outcomes in Marfan syndrome: a nationwide registry. Heart. 2025 (epub). PMID 41475970
  25. Smith K, Gros B. Pregnancy-related acute aortic dissection in Marfan syndrome: a review of the literature. Congenit Heart Dis. 2017;12:251-260. PMID 28371362
  26. Stewart FM. Marfan's syndrome and other aortopathies in pregnancy. Obstet Med. 2013;6:112-119. PMID 27708702
  27. Tadakawa M, Yamaguchi T, Tomita H, et al. Fatal aortic rupture at term pregnancy caused by vascular Ehlers-Danlos syndrome diagnosed by postmortem genetic testing. J Obstet Gynaecol Res. 2026;52:e70299. PMID 42092737
  28. Hatzaras I, Tranquilli M, Coady M, et al. Weight lifting and aortic dissection: more evidence for a connection. Cardiology. 2007;107:103-6. PMID 16847387
  29. Greve D, Funke J, Khairi T, et al. Cocaine-related aortic dissection: what do we know? Braz J Cardiovasc Surg. 2020;35:764-769. PMID 33118742
  30. Matabele M, Newhall K, Drudi LM, et al. Role of illicit drug use in type B aortic dissection and trial participation. Semin Vasc Surg. 2026;39:151-156. PMID 42285641
  31. Pasternak B, Inghammar M, Svanström H. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 2018;360:k678. PMID 29519881
  32. Gopalakrishnan C, Bykov K, Fischer MA, et al. Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection. JAMA Intern Med. 2020;180:1596-1605. PMID 32897307
  33. Mosquera VX, Marini M, Muñiz J, et al. Blunt traumatic aortic injuries of the ascending aorta and aortic arch: a clinical multicentre study. Injury. 2013;44:1191-7. PMID 23294894
  34. Patel HJ, Azizzadeh A, Matsumoto AH, et al. Five-year outcomes from the United States pivotal trial of Valiant Captivia stent graft for blunt aortic injury. Ann Thorac Surg. 2020;110:815-820. PMID 31991136
  35. Fang XX, Wu XH, Chen XF. Blunt aortic injury — traumatic aortic isthmus pseudoaneurysm with right iliac artery dissection aneurysm: a case report. World J Clin Cases. 2022;10:4998-5004. PMID 35801016
  36. Pape LA, Tsai TT, Isselbacher EM, et al. Aortic diameter ≥5.5 cm is not a good predictor of type A aortic dissection: observations from IRAD. Circulation. 2007;116:1120-7. PMID 17709637
  37. Lareyre F, Raffort J, Le D, et al. High neutrophil to lymphocyte ratio is associated with symptomatic and ruptured thoracic aortic aneurysm. Angiology. 2018;69:686-691. PMID 29334754
  38. Agarwal T, Vijay J, Kumar B, Agstam S. Cardiovocal syndrome secondary to thoracic aortic aneurysm: an old sign revisited. Cureus. 2020;12:e10087. PMID 33005510
  39. Chaddha A, Eagle KA, Patel HJ, et al. The clinical impact of imaging surveillance and clinic visit frequency after acute aortic dissection. Aorta (Stamford). 2019;7:75-83. PMID 31614376
  40. Tsai TT, Evangelista A, Nienaber CA, et al. Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med. 2007;357:349-59. PMID 17652650
  41. Dueppers P, Reutersberg B, Rancic Z, et al. Long-term results of total endovascular repair of arch-involving aortic pathologies using parallel grafts for supra-aortic debranching. J Vasc Surg. 2022;75:813-823. PMID 34606961
  42. Lyons OTA, Baguneid M, Barwick TD, et al. Diagnosis of aortic graft infection: a case definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52:758-763. PMID 27771318
  43. Anagnostopoulos A, Mayer F, Ledergerber B, et al. Validation of the MAGIC criteria for the diagnosis of vascular graft/endograft infection: results from the prospective Vascular Graft Cohort study. Eur J Vasc Endovasc Surg. 2021;62:251-257. PMID 34140225
  44. Treasure T, Takkenberg JJM, Pepper J. Surgical management of aortic root disease in Marfan syndrome and other congenital disorders associated with aortic root aneurysms. Heart. 2014;100:1571-6. PMID 24986892